Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Part of paid clinical trials in Pasadena, California.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT00622726
- Phase
- PHASE2
- Status
- Unknown
Conditions
- Retinopathy of Prematurity
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Weeks - 22 Weeks
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab — DRUGAnti-angiogenic drug: intravitreal injection of 0.625 mg (0.025 ml) once into each eye.
- Conventional Laser for ROP — PROCEDUREConventional Laser is applied to the Avascular Peripheral Retina (Anterior to the Vascularized Posterior Retina)
Study Details
The purpose of this study was to determine the efficacy and additional advantages of intravitreal bevacizumab in the treatment of ROP for both Zone I and Zone II Posterior.
Key Dates
- First listed
- Feb 25, 2008
- Start date
- Mar 31, 2008
- Status verified
- May 2017
- Primary completion
- Aug 31, 2010
- Completion
- Aug 31, 2020
Study Design
- Enrollment
- 150 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Bevacizumab for ROPIntravitreal Bevacizumab Therapy is the Experimental Arm of this Study
- Active Comparator: Conventional Laser for ROPConventional Laser to the Peripheral Retina is the Control Arm of this Study
Primary Outcome Measure
Number of Eyes Showing Recurrence of Neovascularization Arising From the Retinal Vessels and Requiring Re-treatment [ Time Frame: 54 weeks postmenstrual age (window of 50 to 70 weeks) ]
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Huntington Memorial Hospital | Pasadena | California | 91109 | - |
| Presbyterian-St. Luke's Hospital | Denver | Colorado | 80218 | - |
| OSF St. Francis Medical Center-Children's Hospital of Illinois | Peoria | Illinois | 61637 | - |
| Palmetto Health Baptist Hospital | Columbia | South Carolina | 29223 | - |
| Palmetto Health Richland Hospital | Columbia | South Carolina | 29203 | - |
| Driscoll Children's Hospital | Corpus Christi | Texas | 78411 | - |
| Baylor University Medical Center | Dallas | Texas | 75346 | - |
| Del Sol Medical Center | El Paso | Texas | 79925 | - |
| Las Palmas Medical Center | El Paso | Texas | 79902 | - |
| R.E. Thomason Hospital | El Paso | Texas | 79905 | - |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | - |
| Children's Memorial Hermann Hospital | Houston | Texas | 77030 | - |
| Memorial Hermann Southwest Hospital | Houston | Texas | 77074 | - |
| St. Joseph Medical Center | Houston | Texas | 77002 | - |
| Clear Lake Regional Medical Center | Webster | Texas | 77598 | - |
Find similar trials in Pasadena, CA
By research site
Huntington Memorial Hospital· Pasadena, CAPresbyterian-St. Luke's Hospital· Denver, COOSF St. Francis Medical Center-Children's Hospital of Illinois· Peoria, ILPalmetto Health Baptist Hospital· Columbia, SCPalmetto Health Richland Hospital· Columbia, SCDriscoll Children's Hospital· Corpus Christi, TX
Related Studies
- Clinical and Genetic Analysis of ROPRecruiting · Oregon Health and Science University · Palo Alto, California
- Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)Recruiting · Duke University · Durham, North Carolina
- Imaging Retinal Vasculature in Infant EyesRecruiting · Duke University · Durham, North Carolina